Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who start HIV treatment early have a normal life expectancy, according to new findings.
Amid talk of “ending HIV,” we must also focus on those with the virus, says Anthony S. Fauci, MD.
But even starting antiretrovirals with a high CD4 count doesn’t close the wide gap in years lived without major health problems.
A study of people at high risk of poor outcomes assessed a program that sought to address numerous needs that may affect their health.
Keeping people with HIV in consistent care and on treatment for the virus is vital to ensure they benefit from an undetectable viral load.
The increasing mastery over the virus is one of humanity’s crowning achievements.
Investigators conducted a review of 20 studies covering 55 health outcomes, looking for those associated with HIV.
Researchers used mathematical modeling to analyze the benefits of treating with buprenorphine/naloxone on-site.
Hepatitis C increases risk of death among people on HIV treatment.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
Researchers analyzed a population of Danish people with the virus and asked them about their perceived life expectancy.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
Treatments to reduce inflammation could help make HIV even less of a threat to health than antiretrovirals can alone.
Michael Friedman, best known for “Bloody Bloody Andrew Jackson,” reportedly found out he had HIV only nine weeks before his death.
A study of 175 HIV-positive French individuals finds.
A new study advises looking at factors such as depression, anxiety and unemployment before pointing the finger at cognitive impairment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.